Gain Therapeutics (GANX)
(Delayed Data from NSDQ)
$2.55 USD
+0.04 (1.59%)
Updated May 31, 2024 04:00 PM ET
After-Market: $2.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.34 | 20.59% |
Earnings Summary
For their last quarter, Gain Therapeutics (GANX) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 26.67%. Look out for GANX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year increase of 45.16%.
Earnings History
Price & Consensus
Zacks News for GANX
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
GANX: What are Zacks experts saying now?
Zacks Private Portfolio Services